The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has been selected to receive a €13 million grant from the Centre for the Development of Industrial Technology (CDTI). 

The neurotechnology company INBRAIN Neuroelectronics, a member of CATALONIA.HEALTH, has received a 4 million euros’ grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative, a national programme to support the most revolutionary innovation in microelectronics, semiconductors and deeptech.

The public-private consortium formed by the biopharmaceutical company Oniria Therapeutics, a member of CATALONIA.HEALTH, the Spanish National Research Council (CSIC) and the Vall d'Hebron Institute of Oncology (VHIO) has obtained 2 million euros of funding from the Ministry of Science, Innovation and Universities of Spain and the European Union, through the Public-Private Collaboration Program 2023. 

CATALONIA.HEALTH incorpora a Arantxa Sanz com a directora general de l’entitat. Amb aquest nou lideratge, s’inicia una nova etapa enfocada a consolidar el seu posicionament dins l’ecosistema i a reforçar les aliances entre el món científic, empresarial i institucional.

The medical diagnostics company Deepull, a member of CATALONIA.HEALTH, has announced the closing of a €50 million Series C financing round. 

New studies emphasize how peptide-based launches, the core of the Gate2Brain technological platform, a member of CATALONIA.HEALTH, are poised to revolutionise drug administration through the blood-brain barrier. 

Why are biotechs booming in Barcelona? Nature, the most prestigious scientific journal in the world, has highlighted three biotech startups based in Barcelona and members of CATALONIA.HEALTH, Nuage Therapeutics, Ona Therapeutics and SpliceBio.

The Board of Trustees of the Josep Carreras Leukaemia Research Institute, a member of CATALONIA.HEALTH, has approved the appointment of Ari Melnick as the new Director of the centre.

The R&D pharma company Accure Therapeutics, a member of CATALONIA.HEALTH, has received two grants totalling 1.6 million of dollars, $1.12M in grants awarded by The Michael J. Fox Foundation (MJFF) and $0.48M by the Luxembourg National Research Fund (FNR) for two separate development programs on its drug candidate ACT-02.

The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, Neurona Therapeutics, has closed a funding round of 102 million dollars. 

The CEO of the biotech company specialized in enhancing the female fertility, Oxolife, a member of CATALONIA.HEALTH, Agnès Arbat, wins the 2025 European Prize for Women Innovators in the Women Innovator category. 

Biotechnology company Gain Therapeutics, member of CATALONIA.HEALTH, announce the dosing of the first participant with Parkinson’s disease in its Phase 1b clinical trial of GT-02287

Biotech company Nuage Therapeutics, member of CATALONIA.HEALTH, has announced the appointment of Stuart Hughes as Chief Executive Officer and Vanessa Malier as Chair of the Board of Directors.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has signed a commercial agreement with LEO Pharma, with the aim to strengthen the promotion of LEO Pharma’s innovative treatment for mild to moderate psoriasis within the scope of Primary Care in Spain.

Asabys Partners, a member of CATALONIA.HEALTH, has announced that its investee Augustine Therapeutics, has closed a Series A financing round, raising a total of 85 million dollars. 

i4KIDS, the Paediatric Innovation Hub at Sant Joan de Déu Barcelona Children's Hospital, member of CATALONIA.HEALTH, has been awarded the National Award for Knowledge Transfer Promotion 2024 by the Catalan Foundation for Research and Innovation (FCRI) and the Government of Catalonia. 

The technological company Neos Surgery, a member of CATALONIA.HEALTH, has received the Innovation Award at the VIII edition of the Spanish SME of the Year Award 2024, held in Madrid. 

The gene therapy biotechnology company SpliceBio, a member of CATALONIA.HEALTH, announced that it has dosed the first patient in the Phase 1/2 ASTRA study of SB-007, a dual adeno-associated viral (AAV) vector, for the treatment of Stargardt disease.

The health sector plays a key role in the digital world we live in. That is why digital health has had an important place at the 2025 edition of 4YFN, the event parallel to the Mobile World Congress (MWC), which is a benchmark for the international entrepreneurial ecosystem, and that is why CATALONIA.HEALTH was there to showcase examples of the best local medical device technologies. CATALONIA.HEALTH successfully met a new challenge, as it participated in this event for the first time.

The biotech company CONNECTA Therapeutics, a member of CATALONIA.HEALTH, has announced positive results from its Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics profile of its drug candidate CTH120 in adult volunteers.